The Journal of pharmacy and pharmacology
Endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine ameliorates lipopolysaccharide-induced airway inflammation and bronchial hyperreactivity in mice.
Yasemin Karaman, Yesim Kaya-Yasar, Sevgen Celik Onder, Turgut Emrah Bozkurt, Inci Sahin-Erdemli
Published: 202510.1093/jpp/rgaf112
Abstract
OBJECTIVES: Asymmetric dimethylarginine (ADMA) is an endogenous nitric oxide synthase inhibitor. ADMA concentrations are augmented in lung, plasma samples of asthmatics. It remains unclear whether the increased concentration of ADMA in airway inflamm…
Preview only. Read the full abstract at the source